Lobe Sciences

Lobe Sciences Ltd. is a biopharmaceutical company based in Vancouver, Canada, focused on discovering and developing innovative treatments for rare and chronic diseases. Formerly known as Greenstar Biosciences Corp., the company specializes in drug research and development aimed at enhancing brain health and overall wellness. Lobe Sciences is actively working on a medical food called Altemia, intended for the treatment of Sickle Cell Disease, and has a pipeline that includes L-130 for Chronic Cluster Headache, L-131 for Pediatric Anxiety, and S-100 also targeting Sickle Cell Disease. The company's mission centers on creating impactful therapies for patients with significant unmet medical needs.